Low-intensity ultrasound to calm the nerves and improve sleep after heart surgery
Official title: Low-Intensity Focused Ultrasound Targeting the Stellate Ganglion for Regulating Autonomic Nerve Function and Sleep Quality in Perioperative Patients With Cardiovascular Diseases: A Multicenter, Double-Blind, Randomized Controlled Trial
Run by Renmin Hospital of Wuhan University · NCT07595068 · Data updated 2026-11-12
This trial tests whether gentle, focused ultrasound on the left stellate ganglion can improve autonomic function and sleep after heart-related surgery in adults with cardiovascular disease, compared with a sham treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 79 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Renmin Hospital of Wuhan University Academic / other |
| Locations | 7 sites (Huangshi, Hubei and 6 other locations) |
| Status | Recruiting |
| Started | May 20, 2026 |
| Main results expected | April 1, 2027 |
| Study ends | April 1, 2027 |
| Registry record updated | August 21, 2026 |
| Trial ID | NCT07595068 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–79 with cardiovascular disease scheduled for cardiology-related surgery who consent to randomization and can tolerate the procedure.
✕Probably not a fit
Patients with impaired sleep or autonomic function changes not responsive to the intervention, or those unable to complete daily treatment, may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, double-blind, randomized controlled trial will enroll adults with cardiovascular disease undergoing cardiology-related surgery. Participants will receive either active low-intensity focused ultrasound targeting the left stellate ganglion or a sham procedure, daily for 3–7 days, in addition to standard care. The study will assess heart rate variability, sleep quality, serological markers, vital signs, and perioperative arrhythmias, with safety monitored closely. The design includes blinding of participants, operators, assessors, and analysts to minimize bias. The trial is led by Renmin Hospital of Wuhan University with several collaborating centers in Hubei province and is expected to begin in May 2026.
Why it matters
Potential benefit: If successful, patients may experience better autonomic regulation and sleep after surgery, potentially improving recovery after cardiovascular procedures.
How similar studies have gone: Prior studies in related neuromodulation approaches have shown signals of autonomic and sleep effects, but this exact LIFU stellate ganglion method in perioperative CVD patients is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Diagnosed with cardiovascular disease (CVD) and scheduled to undergo cardiology-related surgical treatment 2. Able to receive and tolerate the aforementioned cardiology-related surgical treatment 3. Aged between 18 and 79 years (inclusive), with no restriction on gender 4. Agree to accept random allocation of the treatment strategies 5. With clear consciousness, no severe mental disorders or cognitive impairment; voluntarily sign the written informed consent form (ICF) and are willing to actively cooperate with the study treatment Exclusion Criteria: 1. Have used sedative-hypnotic drugs, antipsychotic drugs, opioid analgesics, antihistamines, non-steroidal anti-inflammatory drugs (NSAIDs), central nervous system (CNS) stimulant drugs, or any other medications that alter sleep architecture within the past 30 days 2. Have a history of cervical infection, trauma, severe cervical deformity, or prior cervical surgery 3. Unable to complete the daily study intervention as required by the trial protocol 4. Are participating in another clinical trial, or have participated in other clinical trials with interventions that may interfere with the results of this study 5. Have undergone major surgery or general anesthesia within the past 30 days 6. Have a history of alcohol abuse 7. Are female subjects who are pregnant or lactating, or plan to become pregnant during the study period 8. Have severe cognitive impairment, severe psychiatric disorders, epilepsy, or other related neurological disorders 9. Have concomitant malignant tumor or severe dysfunction of vital organs 10. Have active systemic infection 11. Have significant bleeding tendency, or renal failure undergoing regular hemodialysis 12. Are deemed unsuitable for the trial by the investigator for any other reason -
Where it's running
-
Renmin Hospital of Wuhan University
Wuhan, Hubei, China Recruiting -
Huangshi Central Hospital
Huangshi, Hubei, China Not yet recruiting -
Jingzhou Central Hospital
Jingzhou, Hubei, China Not yet recruiting -
Wuhan Central Hospital
Wuhan, Hubei, China Not yet recruiting -
Wuhan Third Hospital
Wuhan, Hubei, China Not yet recruiting -
Xiangyang Central Hospital
Xiangyang, Hubei, China Not yet recruiting
Show 1 more location
-
Yichang Central People's Hospital
Yichang, Hubei, China Not yet recruiting
Study contacts
- Study coordinator: Songyun Wang, MD
- Email: wsy7982@126.com
- Phone: +86 13871262107
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Pulsed Field vs Cryoballoon for Pulmonary Vein Isolation in Atrial Fibrillation
This trial tests whether pulsed field ablation can shorten the procedure for first-time PVI in AF patients compared with cryoballoon ablation, while keeping safety and effectiveness similar.
-
Pulsed Field Ablation vs Cryoablation for Atrial Fibrillation Under Deep Sedation
This trial tests whether pulsed field ablation (PFA) done under deep sedation works as well as cryoballoon ablation for treating atrial fibrillation, aiming to avoid general anesthesia.
-
Bachmann’s Bundle Pacing vs Right Atrial Appendage Pacing for AF
This study tests two common atrial pacing methods to see which one is safer over 12 months for people getting a new pacemaker, ICD, or CRT device.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
Pace-and-ablate strategy in atrial fibrillation: who benefits and long-term outcomes
This study looks at adults with atrial fibrillation who underwent AV node ablation with permanent pacing to see who develops pacing-induced problems and how they do long-term.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.